Healthcare Stocks Top News Virpax Pharmaceuticals Reports on FDA Pre-IND Response for NobrXiol™ (formerly VRP324) –VRPX Intranasal Cannabidiol Product Candidate for Management of Epilepsy in Children and… Ryan AllwayDecember 14, 2022